MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
about
Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy.The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.Inflammation and epigenetic regulation in osteoarthritis.A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus.Epigenetic Regulations in Diabetic Nephropathy.microRNA profiling in atherosclerosis, diabetes, and migraine.Interplay between miRNAs and human diseases.The Management of Cardiovascular Risk through Epigenetic BiomarkersIdentification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic NephropathyElectrochemical detection of urinary microRNAs via sulfonamide-bound antisense hybridisation.MiR-27b augments bone marrow progenitor cell survival via suppressing the mitochondrial apoptotic pathway in Type 2 diabetes.A more tubulocentric view of diabetic kidney disease.Urinary miR-21 as a potential biomarker of hypertensive kidney injury and fibrosis.Biomarkers of diabetic nephropathy: A 2017 update.Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma.Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy
P2860
Q33633674-947CB840-A912-46BA-BD91-428D618B7EA8Q37493523-89133B2C-A8CA-41B0-9C28-53DAE7335D85Q37541642-A665A67E-BCFF-4A54-8BE1-430ED173B618Q37606976-498D41F7-F4E8-4803-96C7-9CA43647FB40Q37728970-066DBA4A-AE72-42A6-B92B-FD23C3C6FC7BQ37733522-F2D795DB-C944-452E-8CBC-1EB7BAE3291BQ38827929-D764F012-0CD9-4647-9823-B67C7588624DQ39127898-48D51869-805A-4DD0-9A30-650D3606D703Q41146679-6D9D2E39-B0BF-4FCB-AA06-379A719E3298Q41695917-87A0B990-217D-45EB-AC75-F4A61C1264CCQ45922728-CBCAB48A-CC31-4E63-B48E-B61BFADDCEC7Q46337431-929BE403-FDB4-4FC4-8B3C-90A50760DECFQ47108081-ACDD3384-D24F-429A-AD5E-50179552DD0EQ47110212-E6889648-51E0-4637-810C-1A52B8395955Q49686004-EE5B7E15-8A91-4C69-A9AB-C0A6E70716ACQ52630076-35A1E076-2F92-49FD-A1F2-52C3635948ADQ52657763-ECF56674-9774-499C-9EB1-53A14CF6BF77Q58998162-946EB3BC-505D-4BA4-A6BE-9492DB35B79B
P2860
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@ast
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@en
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@nl
type
label
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@ast
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@en
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@nl
prefLabel
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@ast
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@en
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@nl
P2093
P2860
P1476
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
@en
P2093
Donald J Fraser
Kate Simpson
Timothy Bowen
P2860
P2888
P356
10.1007/S11892-016-0724-8
P407
P577
2016-03-01T00:00:00Z
P5875
P6179
1024067333